Robert Hawkins

Direktor/Vorstandsmitglied bei BIVICTRIX THERAPEUTICS PLC

Vermögen: 32 945 $ am 31.05.2024

69 Jahre

Health Technology

Consumer Services

Aktive Positionen von Robert Hawkins

Unternehmen	Position	Beginn	Ende
BIVICTRIX THERAPEUTICS PLC	Direktor/Vorstandsmitglied	22.09.2021	-
BIVICTRIX THERAPEUTICS PLC	Independent Dir/Board Member	22.09.2021	-

Unternehmen	Position	Beginn	Ende
INSTIL BIO, INC.	Technik-/Wissenschafts-/F&E-Leiter	11.11.2022	01.05.2024
INSTIL BIO, INC.	Direktor/Vorstandsmitglied	01.02.2019	01.07.2020
Instil Bio (UK) Ltd.	Vorstandsvorsitzender	-	01.01.2020
Instil Bio (UK) Ltd.	Gründer	-	01.01.2020
The University of Manchester	Corporate Officer/Principal	-	-
MOTIF BIO PLC	Direktor/Vorstandsmitglied	14.06.2021	-

University of Cambridge	Doctorate Degree
University College London	Doctorate Degree

International

Vereinigtes Königreich	7
Vereinigte Staaten	2

Operativ

Director/Board Member	3
Doctorate Degree	2
Independent Dir/Board Member	1

Sektoral

Health Technology	4
Consumer Services	4

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	2
BIVICTRIX THERAPEUTICS PLC	Health Technology
INSTIL BIO, INC.	Health Technology

Private Unternehmen	2
Motif Bio Plc Motif Bio Plc Pharmaceuticals: MajorHealth Technology Motif Bio Plc is a clinical stage biopharmaceutical company, which engages in the development and commercialization of pharmaceutical formulations. The company focuses on developing novel antibiotics designed to be effective against serious and life-threatening infections caused by multi-drug resistant bacteria. It offers Iclaprim, a novel diaminopyrimidine antibiotic that inhibits an essential bacterial enzyme called dihydrofolate reductase. The company was founded by Jonathan E. Gold on November 20, 2014 and is headquartered in Princeton, NJ.	Health Technology
Instil Bio (UK) Ltd.

Private Unternehmen

Health Technology

Instil Bio (UK) Ltd.